Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK
Public Health
.
2017 Jan:142:46-49.
doi: 10.1016/j.puhe.2016.10.013.
Epub 2016 Nov 18.
Authors
L Varghese
1
,
D Curran
2
,
E Bunge
3
,
H Vroling
3
,
F van Kessel
3
,
A Guignard
2
,
G Casabona
2
,
A Olivieri
2
Affiliations
1
GSK Vaccines, Singapore. Electronic address: lijoy.x.varghese@gsk.com.
2
GSK Vaccines, Wavre, Belgium.
3
Pallas Health Research and Consultancy, Rotterdam, Netherlands.
PMID:
28057197
DOI:
10.1016/j.puhe.2016.10.013
No abstract available